ABT ▼ -0.4% - Abbott Laboratories $ABT - Abbott presents new ESMO data showing 30-percent absolute improvement in sensitivity with the whole-genome sequencing Oncodetect® test in colorectal cancer 23-OCT-2026 09:17 AM ET